SCHEMBL2216980

SCHEMBL2216980

CCCCCCCCCCCCCCC(O)(CO)C(O)=Cc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.47
LMNA P02545 1/20 0.44
GAA P10253 1/20 0.43
EGFR P00533 1/20 0.40
TNNC1 P63316 6/20 0.38
S1PR1 P21453 2/20 0.38
SGPL1 O95470 1/20 0.38
S1PR4 O95977 1/20 0.38
GPR183 P32249 1/20 0.38
CERS2 Q96G23 1/20 0.38
S1PR3 Q99500 1/20 0.38
S1PR5 Q9H228 1/20 0.38
TUBB4A P04350 2/20 0.37
TUBB P07437 2/20 0.37
TUBA3C P0DPH7 2/20 0.37
TUBA1B P68363 2/20 0.37
TUBA4A P68366 2/20 0.37
TUBB4B P68371 2/20 0.37
TUBB3 Q13509 2/20 0.37
TUBB2A Q13885 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2215035 1.00 TDP1 (0.47) TDP1LMNAGAAEGFRTNNC1
SCHEMBL2219057 1.00 TDP1 (0.47) TDP1LMNAGAAEGFRTNNC1
SCHEMBL2361798 0.87 GAA (0.41) TDP1LMNAGAA
SCHEMBL8055183 0.74 TDP1 (0.52) TDP1LMNAEGFRTUBB4ATUBB
SCHEMBL23406262 0.70 EGFR (0.50) TDP1LMNAGAAEGFRTUBB4A
Alcohol SCHEMBL10990969 0.70 EGFR (0.47) TDP1LMNAGAAEGFRTNNC1
SCHEMBL2362850 0.70 ALDH1A1 (0.39) LMNA
SCHEMBL10011783 0.69 SIGMAR1 (0.42) GAATNNC1S1PR1SGPL1S1PR4
SCHEMBL1238436 0.68 ALDH1A1 (0.40) LMNA
SCHEMBL31718808 0.68 TDP1 (0.65) TDP1LMNAEGFRTUBB4ATUBB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110177156-A1 Sterol-Modified Amphiphilic Lipids THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2011-07-21 US disclosed
CN-101909581-A Sterol-modified amphiphilic lipids UNIV CALIFORNIA 2010-12-08 CN disclosed
EP-2219587-A1 STEROL-MODIFIED AMPHIPHILIC LIPIDS The Regents of the University of California (US) 2010-08-25 EP disclosed
WO-2009064696-A1 STEROL-MODIFIED AMPHIPHILIC LIPIDS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2009-05-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110177156-A1 Sterol-Modified Amphiphilic Lipids SREBF1, SREBF2, SGMS1 TDP1 3661/4885LMNA 500/4885GAA 1616/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.